(14:34 GMT) TG Therapeutics Price Target Raised to $20.00/Share From $17.00 by B of A Securities
Dow Jones Newswires
TG Therapeutics Is Maintained at Underperform by B of A Securities
- Sources
- Dow Jones Newswires
- Markets
- Stocks
- Active symbols
- NASDAQ:TGTX
- Language
- English (India)